Introduction
Peyronie's disease is a localized connective tissue disorder, which results from increased cellular proliferation and excess extracellular matrix production within the tunica albuginea of the penis. It is characterized by the development of a fibrous plaque within the tunica, which restricts expansion in both longitudinal and transverse directions. This restriction may result in curvature of the penis during erection, 1,2 which may result in the inability to participate in sexual intercourse. 3 The disease is estimated to affect approximately 0.4-3% of the male population, 4, 5 and predominately affects middle-aged men. However, despite several centuries of clinical recognition, the exact etiology of this condition has eluded researchers. While trauma to the erect penis is considered to be the inciting event, 6 it is postulated that other cofactors need to be present for Peyronie's disease to develop. A variety of mechanisms have been proposed in the literature, including increased levels of fibrogenic cytokines, 7, 8 chromosomal instability, 9,10 vasculitis of the subtunical space 11 and T-cell autoimmune response 12 among others. Various treatments have been utilized for Peyronie's disease with varying rates of success. Therapeutic strategies that have been employed include oral, intralesional and transdermal agents. [13] [14] [15] [16] Unfortunately, large-scale, prospective, placebo-controlled studies of these treatments in humans are lacking and are complicated to design, making it difficult to compare the value of different treatments. The availability of an animal model would be invaluable to the study of the effect of different treatments on this disease process.
To further study the cellular biology of Peyronie's disease, cell cultures have been established using plaque tissue obtained at the time of surgical reconstruction. We have previously demonstrated that Peyronie's disease fibroblasts undergo cellular alterations, including immortalization in culture, loss of contact inhibition with foci development, consistent morphologic transformation, high-percentage S-phase on flow cytometery, 17 growth in 0.1% fetal calf serum, cytogenetic instability 10 and stabilization and inactivation of p53. 18 This conglomeration of cellular changes suggests that these cells are biologically transformed, a phenomenon routinely seen with neoplastic cells, however, not seen with cells derived from benign processes.
Severe combined immunodeficient (SCID) mice possess a congenital combined deficiency of both T-and B-lymphocyte function. 19 This defect allows the acceptance of foreign tissue, both malignant and benign, that would otherwise be rejected by an intact immune system. These properties have allowed the development of animal models for research in many areas where it was not previously possible, including solid and hematologic malignancies. 20 ,21 SCID mice have also been used in the exploration of benign diseases. 22, 23 Cells that demonstrate tumorigenic potential are by definition biologically transformed. The purpose of this investigation was to determine if fibroblasts derived from Peyronie's disease plaque tissue possess tumorigenic potential in the SCID mouse model and thus, determine definitively if these cells are biologically transformed.
Methods

Study population
The study population consisted of patients with documented Peyronie's disease and penile curvature of at least 1-y duration who underwent either surgical correction of their penile curvature or placement of a penile prosthesis. Patients were enrolled according to a protocol approved by the institutional review board at our institution.
Tissue acquisition
Intraoperatively, a biopsy was taken from the Peyronie's disease plaque. Care was taken to ensure that all of the overlying fascial tissue was stripped from the plaque under loupe magnification. Immediately following excision, the specimen was placed into tissue transport medium (RPMI, 10% fetal calf serum, 10 mM HEPES, ciprofloxacin) and transported directly to the laboratory. Neonatal foreskins and tunical tissue excised (as outlined above) from patients with congenital penile curvature were used as control tissues and were handled in an identical manner.
Cell culture and characterization
Using sterile technique, all tissues were cut into 1 mm 3 fragments and separately placed into 50 ml sterile centrifuge tubes containing MEM (JRH Scientific, Lenexa, KS, USA) supplemented with 10% fetal calf serum (JRH), 1% glutamine, ciprofloxacin (Bayer, Germany), and 0.5 mg/ml type H Collagenase (Sigma, St Louis, MO, USA). Following overnight incubation (generally 16-18 h) at 371C in 5% CO 2 , cells and tissue fragments were collected by centrifugation (400 g Â 5 min) and washed in fresh tissue culture medium. Pieces of digested tissue were carefully placed on to the bottom of 25 cm 2 sterile tissue culture flasks along with cells from the pellet, and incubated in tissue culture medium (MEM/10% FCS/1% glutamine, antibiotics) in 5% CO 2 at 371C. Tissue culture medium was changed after the first 48 h in culture, and subsequently every 5-6 days.
As soon as confluent monolayers were established, cells were harvested using trypsin/EDTA. After washing, cells for continuous cultures were routinely split 1:3 and grown until reaching confluence. At selected passage numbers, cells from each culture were stored in RPMI/15% FCS/7.5% DMSO at À901C. Cells established in tissue culture were characterized for expression of intermediate filament proteins, and for actin-containing microfilaments using indirect immunofluorescence. Individual chambers were incubated with antibodies to vimentin (DAKO, Carpenteria, CA, USA), cytokeratin (BD Bioscience, San Jose, CA, USA), or smooth muscle specific actin (DAKO). All experiments included chambers incubated with appropriate mouse isotope controls at the same final protein concentration as used for primary monoclonal antibodies. Primary antibodies were incubated at 41C for 60 min, followed by washing three times with cold PBS containing 5% BSA, and incubation with secondary antibody (FITC-Goat anti-mouse Ig, final dilution 1:20)(BD Bioscience) for 30 min. Following washing (3 Â with cold PBS/ 5% BSA), nuclei were counterstained using propidium iodide (1 mg/ml), and slides were coverslipped following the addition of anti-fade solution. Chamber slides were viewed using a Zeiss Axioscope fluorescence microscope using epifluorescence illumination.
Animal inoculation and handling
Male BALB/C SCID mice, 8 weeks old (Taconic, NY, USA) were injected subcutaneously on the back with high-passage (passage 32-34) cultured fibroblasts established from Peyronie's disease plaquetissue (n ¼ 10), low-passage (passage 8) normal tunica-derived fibroblasts (n ¼ 5) and low-passage (passage 10) fibroblasts derived from neonatal foreskins (n ¼ 5). Firstly, cells were harvested and suspended in tissue medium as described above to create a slurry. The mice were then inoculated according to an animal care committee-approved protocol. A 20-gauge needle was inserted into the back of the mouse just caudal to the neck line. The needle was then tunneled subcutaneously to the rump where the slurry was injected. The inoculation was performed with a cell density of 5 Â 10 6 in a volume of 0.2 ml. The animals were evaluated daily by the veterinary staff and maintained in isolation for 3 months from the time of inoculation. The animals were fed irradiated food and water and housed in a specific pathogen-free (SPF) environment.
The animal inoculation and handling were identical for each of the three groups. At 3 months after the date of inoculation, irrespective of whether a subcutaneous nodule was present or not, the animals were killed using CO 2 intoxication and cervical dislocation. In all animals, the area of the inoculation was exposed through a dorsal midline incision over the rump and any nodule tissue was excised. All animals also underwent exploration of the peritoneal cavity and retroperitoneum through a ventral midline incision, to assess for the presence of peritoneal or retroperitoneal lesions.
SCID nodule handling
The excised subcutaneous nodules were subdivided and portions were (i) fixed in formalin, (ii) placed in OCT for future immunohistochemistry, and (iii) placed in liquid nitrogen for future analyses. For this investigation, the tissue was analyzed using histological and immunohistochemical staining, including histological stains (H&E,
Results
All of the SCID mice inoculated with cultured Peyronie's disease plaque-derived cells developed subcutaneous nodules at a mean time period of 2.5 þ 0.5 months following injection (Figures 1 and  2 ). All tumors were removed easily en bloc without any evidence of local invasion into the dermis or deeper structures. On gross inspection of the peritoneal and retroperitoneal cavities, no lesions were found. The mean maximum dimension and weight of the nodules was 1.170.2 cms and 0.670.2 g, respectively. No nodules were found in the animals inoculated with cells cultured from either normal tunica or neonatal foreskins.
Histologically, the excised nodule tissue was composed of large, epithelioid cells arranged in cords and nests. Cells demonstrated significant Figure 5) . Immunohistochemically, the tumor, despite its striking epithelioid morphology was positive for vimentin ( Figure 6 ) and negative for cytokeratin supporting the fibroblast origin of the tissue. The robust staining for the mesenchymalderived intracellular filament vimentin is consistent with similar staining in the cells prior to SCID mouse inoculation.
Discussion
The exact cause of Peyronie's disease remains poorly understood. The inciting event is most likely trauma to the erect or semierect penis, however, trauma alone may not fully explain the pathogenesis of this condition. The condition often follows a selflimiting course and the patient may improve over The fact that it took more than 2 months for these nodules to become palpable is not surprising. Of the 5 million cells injected, it is likely that a minority survived and that only a small cohort of cells generated the eventual lesion. In contrast, neither sets of SCID mice injected with normal tunicaderived or neonatal foreskin-derived cells developed subcutaneous nodules. While there was a significant difference in the passage number between control and plaque-derived fibroblasts, it is not believed that the tumorigenic capability of the cells was related to the difference in cell passage number. The main reason for using low passage control cells was that these fibroblasts do not grow past passage 15-20 in our laboratory (as is usual in normal fibroblasts). In contrast, Peyronie's disease plaque-derived fibroblasts at high passage were utilized because they are the most rapidly growing cells and were felt to have the best chance of growing after SCID mouse inoculation. Current experiments are aimed at inoculating these animals with low passage, premorphologically transformed plaque-derived fibroblasts. Histologically, the excised nodules had features of an epithelioid sarcoma, specifically, cells with a high mitotic index with cells of mesothelial origin (which is based on the positive vimentin staining and negative cytokeratin staining) organized into cord-like structures. There was no significant extracellular collagen deposition, therefore the nodules failed to replicate the architecture of a Peyronie's disease plaque and therefore this particular model clearly does not represent an animal model of Peyronie's disease, but confirms the biologically transformed nature of Peyronie's disease plaquederived fibroblasts. Biological transformation is a significant event in cell biology terms and is seen routinely in malignant cells but is generally not a feature of cells derived from benign conditions. Indeed, up until now, there is only one report of a spontaneously immortalized human fibroblast population. 24 The tendency of human fibroblasts to become immortalized in culture and undergo transformation is rare due to the short length of human telomeres. SCID mice were first described by Bosma et al 19 as a tool for studying lymphocyte differentiation and the relationship between lymphocyte deficiency and lymphomas, and since its introduction has been used in many areas of basic science research. It has served as a well-recognized animal model for malignant disease and hematological disorders but more recently has been used in the study of benign diseases. [20] [21] [22] [23] 25 Awwad et al 22 in an attempt to develop an animal model for endometriosis, studied the results of blind intra-peritoneal injection of endometrial tissue into SCID mice. They found a 96% successful implantation rate and conservation of normal morphologic features on staining of the tissue. Furthermore, the endometrial tissue retained functional responsiveness to hormonal manipulation after progesterone supplementation. Fukuda et al 23 studied the morphology and function of normal thyroid tissue in SCID mice and found similar results. The thyroid tissue maintained viability up to 3 y and retained the ability to sequester radioiodine and secrete thyroid hormone in response to thyroid stimulating hormone administration. It is noteworthy that, to date, the analyses of benign disorders using SCID mouse models have used tissue or tissue homogenates but not cultured cells.
The findings of this current study sheds further light on the pathobiology of Peyronie's disease plaque-derived fibroblasts. These data confirm that fibroblasts derived from Peyronie's disease plaque tissue are biologically transformed, however, the cause of this is not clear. A concern is that these findings might represent an artefact of culture technique and maintenance, however, neither tunical fibroblasts from patients with congenital penile curvature nor fibroblasts derived from neonatal foreskins, which have been harvested and maintained in an identical environment, have ever demonstrated any in vitro signs of biologic transformation. Furthermore, the SCID mice injected with the two sets of control cells failed to produce any subcutaneous nodules. The in vitro indicators of biologic transformation that we have demonstrated in our cultured cells have been found consistently in all 10 established cell cultures, each derived from a separate individual with Peyronie's disease. We postulate that the plaque tissue excised for these experiments harbors a small but well-defined population of fibroblasts, which generate the large populations of cells in culture.
It is known that Peyronie's disease is not a premalignant lesion and there is no known increased risk of other cancers in association with Peyronie's disease. The findings from this study in no way imply that patients or clinicians should be concerned about malignant transformation of Peyronie's disease plaque. In this model, Peyronie's disease plaque-derived fibroblasts behaved in a highly pathological manner, replicating the pathobiology demonstrated in culture. It is our postulate that the difference in behavior between Peyronie's disease plaque and the plaque-derived fibroblasts injected into SCID mice suggests that, in the human body there are in vivo factors at play which limit cell growth. Indeed, it is possible that such factors may be responsible for the spontaneous resolution of plaques in some patients. The importance of these findings will only be fully defined with future work. Planned experiments are aimed at defining the factor or factors that induce the transformed state in the Peyronie's disease plaque-derived fibroblasts.
Summary
The cultured Peyronie's disease plaque-derived cells in our experiments demonstrate the hallmarks of biologic transformation. Consistent with the in vitro findings, the cells demonstrate tumorigenic potential in the SCID mouse model. While not an animal model for Peyronie's disease, this model is an interesting experiment in cell biology, and further supports the pathobiology of these cells and the condition of Peyronie's disease. Future work is aimed at identifying the factor(s) that is responsible for the biologic transformation of Peyronie's disease plaque-derived cells.
